| Israel exports to Colombia · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Italy · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Japan · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Rep. of Korea · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Mexico · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Poland · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to India · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Spain · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Switzerland · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Brazil · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Japan · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Mexico · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Switzerland · Heterocyclic compounds: containing an unfused furan ring (whether or not hydrogenated) in the structure, tetrahydrofuran | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Heterocyclic compounds: lactones, other lactones excluding those of item no. 2932.21 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Heterocyclic compounds: lactones, other lactones excluding those of item no. 2932.21 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to India · Heterocyclic compounds: lactones, other lactones excluding those of item no. 2932.21 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Switzerland · Heterocyclic compounds: lactones, other lactones excluding those of item no. 2932.21 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Heterocyclic compounds: lactones, other lactones excluding those of item no. 2932.21 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Canada · Heterocyclic compounds: n.e.s. in heading no. 2932 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Heterocyclic compounds: n.e.s. in heading no. 2932 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Argentina · Heterocyclic compounds: n.e.s. in heading no. 2932 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Australia · Heterocyclic compounds: n.e.s. in heading no. 2932 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Japan · Heterocyclic compounds: n.e.s. in heading no. 2932 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Rep. of Korea · Heterocyclic compounds: n.e.s. in heading no. 2932 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Mexico · Heterocyclic compounds: n.e.s. in heading no. 2932 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Heterocyclic compounds: n.e.s. in heading no. 2932 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Spain · Heterocyclic compounds: n.e.s. in heading no. 2932 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Switzerland · Heterocyclic compounds: n.e.s. in heading no. 2932 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Brazil · Heterocyclic compounds: n.e.s. in heading no. 2932 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to United Kingdom · Heterocyclic compounds: n.e.s. in heading no. 2932 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Heterocyclic compounds: n.e.s. in heading no. 2932 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to India · Heterocyclic compounds: containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, other than those of item no. 2933.11 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Heterocyclic compounds: containing an unfused imidazole ring (whether or not hydrogenated) in the structure, hydantoin and its derivatives | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Heterocyclic compounds: containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Rep. of Korea · Heterocyclic compounds: containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Spain · Heterocyclic compounds: containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Heterocyclic compounds: containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Canada · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Rep. of Korea · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Spain · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Brazil · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to United Kingdom · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Canada · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Rep. of Korea · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Canada · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Australia · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Italy · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Japan · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Rep. of Korea · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Mexico · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Other Asia, nes · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Philippines · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Singapore · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Spain · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Switzerland · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Brazil · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Türkiye · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to United Kingdom · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Colombia · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Japan · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Rep. of Korea · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Other Asia, nes · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to India · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Spain · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Türkiye · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to United Kingdom · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Canada · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Argentina · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Italy · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Japan · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Rep. of Korea · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Mexico · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Other Asia, nes · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Spain · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Switzerland · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Brazil · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Türkiye · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Canada · Heterocyclic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Heterocyclic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Heterocyclic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
Research Data